Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis-Reference-Cited by-同舟云学术

Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis

Published:2016-03-04 Issue:14 Volume:86 Page:1287-1295
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Zhang Tingting,Tremlett Helen,Leung Stella,Zhu Feng,Kingwell Elaine,Fisk John D.,Bhan Virender,Campbell Trudy L.,Stadnyk Karen,Yu B. Nancy,Marrie Ruth Ann,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Reference33 articles.

1. Multiple sclerosis: diagnosis and the management of acute relapses

2. Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis

3. Comorbid Illness is Associated with Survival and Length of Hospital Stay in Patients with Chronic Disability

4. An adverse lipid profile is associated with disability and progression in disability, in people with MS

5. The Framingham cardiovascular risk score in multiple sclerosis

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current understanding of cardiovascular autonomic dysfunction in multiple sclerosis;Heliyon;2024-08

2. Association of Clinical Relapses With Disease Outcomes in Multiple Sclerosis Patients Older Than 50 Years;Neurology;2024-07-23

3. Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability?;Current Neuropharmacology;2024-07

4. Impact of multiple sclerosis comorbidities on quality of life and job activity;Multiple Sclerosis Journal;2024-06-24

5. Management of multiple sclerosis in older adults: review of current evidence and future perspectives;Journal of Neurology;2024-04-30